A carregar...

Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy

Women with breast cancer who receive adjuvant therapy are at risk for developing therapy-related myelodysplastic syndrome (MDS) or AML (tMDS/AML). Patients with tMDS/AML are often referred for consideration of allogeneic hematopoietic SCT (HSCT). However, the outcomes of HSCT in such patients have n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Armand, P, Kim, HT, Mayer, E, Cutler, CS, Ho, VT, Koreth, J, Alyea, EP, Antin, JH, Soiffer, RJ
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889243/
https://ncbi.nlm.nih.gov/pubmed/20154738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2010.20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!